Gem Hopkins
Investor Relations Contact chez SILENCE THERAPEUTICS PLC
Profil
Gem Hopkins is currently working as the VP-Investor Relations & Corporate Communications at Silence Therapeutics Plc.
Previously, Mr. Hopkins worked as the Vice President-Investor Relations at Synergy Pharmaceuticals LLC.
Postes actifs de Gem Hopkins
| Sociétés | Poste | Début |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Investor Relations Contact | 01/08/2020 |
Anciens postes connus de Gem Hopkins
| Sociétés | Poste | Fin |
|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Investor Relations Contact | 01/11/2018 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
